Lake S, Gaddis A, Tupper KW, Nosova E, DeBeck K 3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) use and transitions to injection drug use among street-involved youth Subst Abus PubMed

Argento E, Tupper KW, Socías ME The tripping point: the potential role of psychedelic-assisted therapy in the response to the opioid crisis Int J Drug Policy PubMed

Argento E, Braschel M, Walsh Z, Socías ME, Shannon K The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women J Psychopharmacol PubMed

Gaddis A, Lake S, Tupper K, Nosova E, Blommaert K, Wood E, DeBeck K Regular MDMA use is associated with decreased risk of drug injection among street-involved youth who use illicit drugs Drug Alcohol Depend PubMed

Lafrance A, Loizaga-Velder A, Fletcher J, Renelli M, Files N, Tupper KW Nourishing the spirit: exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders J Psychoactive Drugs PubMed

Argento E, Strathdee SA, Tupper K, Braschel M, Wood E, Shannon K Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting BMJ Open PubMed

Cloutier-Gill L, Wood E, Millar T, Ferris C, Socías ME Remission of severe opioid use disorder with ibogaine: a case report J Psychoactive Drugs PubMed

Tupper KW, Wood E, Yensen R, Johnson MW Psychedelic medicine: a re-emerging therapeutic paradigm CMAJ PubMed